Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating
Arcutis Biotherapeutics has an 83 Composite Rating, putting it in the top 17% of stocks, regardless of industry.
Source: Investor's Business Daily
Arcutis Biotherapeutics has an 83 Composite Rating, putting it in the top 17% of stocks, regardless of industry.
